GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (OTCPK:BIOAF) » Definitions » Financial Strength

Bioasis Technologies (Bioasis Technologies) Financial Strength : 0 (As of Nov. 2022)


View and export this data going back to 2009. Start your Free Trial

What is Bioasis Technologies Financial Strength?

Bioasis Technologies has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Bioasis Technologies did not have earnings to cover the interest expense. Bioasis Technologies's debt to revenue ratio for the quarter that ended in Nov. 2022 was 3.71. As of today, Bioasis Technologies's Altman Z-Score is 0.00.


Competitive Comparison of Bioasis Technologies's Financial Strength

For the Biotechnology subindustry, Bioasis Technologies's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioasis Technologies's Financial Strength Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's Financial Strength distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's Financial Strength falls into.



Bioasis Technologies Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Bioasis Technologies's Interest Expense for the months ended in Nov. 2022 was $-0.16 Mil. Its Operating Income for the months ended in Nov. 2022 was $-0.52 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2022 was $0.53 Mil.

Bioasis Technologies's Interest Coverage for the quarter that ended in Nov. 2022 is

Bioasis Technologies did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Bioasis Technologies's Debt to Revenue Ratio for the quarter that ended in Nov. 2022 is

Debt to Revenue Ratio=Total Debt (Q: Nov. 2022 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.115 + 0.531) / 0.444
=3.71

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Bioasis Technologies has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioasis Technologies  (OTCPK:BIOAF) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Bioasis Technologies has the Financial Strength Rank of 0.


Bioasis Technologies Financial Strength Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioasis Technologies (Bioasis Technologies) Business Description

Traded in Other Exchanges
N/A
Address
157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies (Bioasis Technologies) Headlines